MUCOPOLYSACCHARIDOSIS VI
Clinical trials for MUCOPOLYSACCHARIDOSIS VI explained in plain language.
Never miss a new study
Get alerted when new MUCOPOLYSACCHARIDOSIS VI trials appear
Sign up with your email to follow new studies for MUCOPOLYSACCHARIDOSIS VI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an arthritis drug ease pain in rare MPS diseases?
Symptom relief OngoingThis study tests whether adalimumab, a drug used for arthritis, can reduce pain and improve joint movement in people with MPS I, II, or VI. It includes 14 children and adults who have significant pain and limited joint motion. Participants receive either adalimumab or a placebo f…
Matched conditions: MUCOPOLYSACCHARIDOSIS VI
Phase: PHASE1, PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
New study offers extra screening for rare diseases in newborns
Knowledge-focused ENROLLING_BY_INVITATIONThis study gives parents the option to have their newborn screened for a panel of rare genetic disorders, in addition to standard newborn screening. Researchers will test 100,000 babies born in New York hospitals to see how accurate the screening is and how often these conditions…
Matched conditions: MUCOPOLYSACCHARIDOSIS VI
Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC